NCT03684252 is a NA clinical trial of CBT-based intervention in Drug Use Disorders, sponsored by University of Puerto Rico.

Who is sponsoring NCT03684252?

NCT03684252 is sponsored by University of Puerto Rico.

What drugs are being tested in NCT03684252?

Interventions in NCT03684252: CBT-based intervention, Treatment as Usual.

What condition does NCT03684252 study?

NCT03684252 studies Drug Use Disorders, HIV/AIDS.

Is NCT03684252 still recruiting?

NCT03684252 is currently completed. Last updated 2 October 2019.

Last reviewed 2019-10-02 · How we verify

NCT03684252

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reducing Self-stigma in Persons With HIV and Drug Use Disorders in Primary Health Care Settings

Completed NA Last updated 2 October 2019

What this trial tests

NA trial testing CBT-based intervention in Drug Use Disorders in 17 participants. Completed in 31 August 2019.

Timeline

9 April 2019

Primary endpoint
25 June 2019

31 August 2019

Quick facts

Lead sponsor	University of Puerto Rico
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	17
Start date	9 April 2019
Primary completion	25 June 2019
Estimated completion	31 August 2019
Sites	1 location across Puerto Rico

Drugs / interventions tested

CBT-based intervention
Treatment as Usual

Conditions studied

Drug Use Disorders — all drugs for Drug Use Disorders →
HIV/AIDS — all drugs for HIV/AIDS →

Sponsor

University of Puerto Rico

Who can join

21 and older, any sex, with Drug Use Disorders or HIV/AIDS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators propose to lay the groundwork for a larger effectiveness clinical trial that will lead to the advancement of a novel evidence-based treatment for DUD and HIV among Spanish-speaking Latinos who suffer from self-stigma and have inadequate treatment adherence. This pilot project aims to: compare the outcomes of a culturally adapted CBT-based intervention to treatment as usual (TAU), in a randomized pilot trial of HIV+ individuals with a lifetime DUD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CBT-based intervention

Trials testing the same drug.

NCT03066531 — MOTIVOB-(Acceptance and Commitment Therapy Group Intervention for Obesity)Section · NA · completed

Other recruiting trials for Drug Use Disorders

Currently open trials in the same condition.

NCT06163651 — Evaluating a One-Year Version of the Parent-Child Assistance Program · NA · recruiting
NCT06729957 — Addressing Barriers to Care for Substance Use Disorder Trial · NA · active not recruiting
NCT06317987 — Addressing Barriers to Care for Substance Use Disorder Pilot Study · NA · active not recruiting
NCT05534568 — The Oklahoma Parent-Child Assistance Program · NA · recruiting
NCT03713983 — Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder · active not recruiting

Other University of Puerto Rico trials

Trials by the same sponsor.

NCT06425510 — Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas · NA · not yet recruiting
NCT07369102 — Esketamine With or Without Integration Therapy for Treatment-Resistant Depression · Phase 4 · recruiting
NCT07039266 — Food Allergy Registry and Awareness Campaign in Puerto Rico · not yet recruiting
NCT06917118 — Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control · NA · not yet recruiting
NCT05910749 — Substance Use Disorder, Brain and Behavioral Regulation · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03684252 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Puerto Rico
Last refreshed: 2 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03684252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing